Evotec AG to Report Fiscal Year 2018 Results on 28 March 2019
HAMBURG, GERMANY / ACCESSWIRE / March 21, 2019 / Evotec AG (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) will report...
user
Hancock Jaffe Enrolls Four Additional Patients for First-in-Human VenoValve Study
Implantations to Take Place by End of April with Initial Data Expected in June 2019 IRVINE, CA / ACCESSWIRE /...
CorMedix Inc. Announces Appointment of Phoebe Mounts as Executive Vice President and General Counsel
BERKELEY HEIGHTS, NJ / ACCESSWIRE / March 21, 2019 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on...
Heat Biologics to Present at the Chinese Society for Clinical Oncology Conference on Immunotherapy
DURHAM, NC / ACCESSWIRE / March 21, 2019 / Heat Biologics, Inc. (NASDAQ: HTBX), a biopharmaceutical company developing immunotherapies designed...
Alimera Sciences Announces Approval for ILUVIEN (R) in Kuwait
Kuwait Added to the Growing Number of Countries with Approval for ILUVIEN in the Middle East ATLANTA, GA / ACCESSWIRE...
Southbridge Fitness Center Announces its Grand Opening in Fort Greene, Brooklyn NY – Brooklyn Borough President Eric Adams to Speak at Grand Opening Celebration
Brooklyn Borough President Eric Adams to speak as Southbridge Fitness Center announces its grand opening on Myrtle Avenue in Fort...
Oryzon to Present Latest Advances of Vafidemstat at Oppenheimer’s 29th Annual Healthcare Conference
Highlighting encouraging preliminary first human data in REIMAGINE Phase IIa trial Complete data on Borderline Personality Disorder (BPD) cohort will...
NanoVibronix Announces Exclusive Agreement for Distribution of PainShield(R) and UroShield(R) in Italy
ELMSFORD, NY / ACCESSWIRE / March 20, 2019 / NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company's...
Topas Therapeutics to Participate at Upcoming Industry and Scientific Conferences
HAMBURG / ACCESSWIRE / March 20, 2019 / Topas Therapeutics GmbH (Topas), a Hamburg, Germany-based private platform company leveraging the...
Jaguar Completes Filing of CMC Technical Section with FDA for Use of Canalevia for Treatment of Chemotherapy-Induced Diarrhea in Dogs
SAN FRANCISCO, CA / ACCESSWIRE / March 20, 2019 / Jaguar Health, Inc. (NASDAQ: JAGX) (''Jaguar'' or the ''Company''), a...
Intellipharmaceutics Receives Nasdaq Listing Determination; To Begin Trading on the OTC Markets System
TORONTO, ON / ACCESSWIRE / March 19, 2019 / Intellipharmaceutics International Inc. (Nasdaq and TSX: IPCI) ("Intellipharmaceutics" or the "Company"),...
Budget 2019: Collaboration is Essential to Success of National Pharmacare
OTTAWA, ON / ACCESSWIRE / March 19, 2019 / Innovative Medicines Canada (IMC) welcomes the measures taken in Budget 2019...
ReShape Lifesciences to Host Fourth Quarter and Full Year 2018 Conference Call on April 1, 2019
SAN CLEMENTE, CA / ACCESSWIRE / March 19, 2019 / ReShape Lifesciences Inc. (OTCQB: RSLS), a developer of minimally invasive...
Schlomo Schmuel & Sunset Foot Clinic set to Relocate in Coming Months
The Sunset Foot Clinic - home of the famous Happy Foot Sad Foot spinning logo on Sunset Boulevard in Silver...
Aytu BioScience Announces Two Recent Publications Highlighting Improved Efficacy and Patient Preference of Natesto Nasal Testosterone over Topical Gels
Natesto ''MY-T study'' - First Study to Demonstrate Improvement of Low T Symptoms in Men After Switching to Natesto from...
Nevada Facility Runs Test of New Processing System
VANCOUVER, BC / ACCESSWIRE / March 19, 2019 / EVITRADE Health Systems Corp. (CSE: EVA, OTCQB: EVAHF) (the "Company") is...
Evotec And GARDP Announce New Partnership To Discover Novel Antibiotics
COLLABORATION EXPLORES OPPORTUNITIES TO SET UP ANTIBIOTIC DISCOVERY AND DEVELOPMENT PLATFORM AND ESTABLISH A JOINT PIPELINE OF NOVEL ANTIBIOTIC ASSETS...
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2019
DORADO, PUERTO RICO / ACCESSWIRE / March 18, 2019 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB: PBSV),...
Cerecor Reports Fourth Quarter and Full Year 2018 Results
-Significant Advancement in Pipeline and Regulatory Milestones-Meets Increased 2018 Revenue Guidance-Announces Net Revenue Guidance of $20-22 Million for 2019 ROCKVILLE,...
Champions Oncology Reports Quarterly Revenue of $6.4 Million
Reiterates Expectations for Revenue Growth of at Least 20% for Fiscal Year 2019 HACKENSACK, NJ / ACCESSWIRE / March 18,...